RO5190591
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for RO5190591, covering 2016-11-02 to 2016-11-02. Get the full timeline:
Most recent: Clinical Trial Update: ANNAPURNA: A Study of The Combination of RO5466731, RO5190591, Ritonavir and Copegus (Ribavirin) With or Without RO5024048 in Patients With Chronic Hepatitis C Who Are Either Treatment-Naïve or Have Previously Experienced a Null Response to Interferon-Based Treatment [Phase 2]